Form 4 for COLL COLLEGIUM PHARMACEUTICAL, INC
Accepted 2024-11-14 00:00:00 ET · period of report 2024-11-12 · accession 0001062993-24-019165 · SEC index · Original document
Summary rows
Aggregated the way they appear in lists: one row per insider, transaction code and security table.
| X | Filed | Traded | Ticker | Insider | Title | Type | Price | Qty | Owned | ΔOwn | Value |
|---|---|---|---|---|---|---|---|---|---|---|---|
| D | 2024-11-14 | 2024-11-12 | COLL | Karnani Vikram | Pres, CEO, Dir | A - Grant | $0.00 | +106.0K | 106.0K | New | $0 |
| D | 2024-11-14 | 2024-11-12 | COLL | Karnani Vikram | Pres, CEO, Dir | A - Grant | $0.00 | +130.3K | 130.3K | New | $0 |
Purchase Sale Sale after option exercise All abbreviations
Every reported transaction
| # | Table | Security | Date | Code | A/D | Shares | Price | Owned after | Own | Exercise / expiry | Underlying | Footnotes |
|---|---|---|---|---|---|---|---|---|---|---|---|---|
| 1 | Common | Common Stock | 2024-11-12 | A | A | 105,972 | $0.00 | 105,972 | D | — | — | (F1) Reflects the grant of restricted stock units ("RSUs"). Each RSU represents a contingent right to receive one share of the Issuer's common stock. Twenty-five percent (25%) of the RSUs shall vest on November 12, 2025, with the balance vesting in three annual installments thereafter, subject to the Reporting Person's continued service with the Issuer. The RSUs will be settled on each applicable vesting date in shares of the Issuer's common stock. |
| 2 | Derivative | Stock Option (Right to Purchase) | 2024-11-12 | A | A | 130,344 | $0.00 | 130,344 | D | $31.41 · — to 2034-11-12 | 130,344 Common Stock | (F2) Twenty-five percent (25%) of the option shall vest and become exercisable on November 12, 2025, with the balance vesting in equal quarterly installments thereafter, subject to the Reporting Person's continued service with the Issuer. |